ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

GPCR Structure Therapeutics Inc

36.07
0.00 (0.00%)
15 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Structure Therapeutics Inc GPCR NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 36.07 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
36.07
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202415:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:10EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEStructure Therapeutics Reports First Quarter 2024 Financial..
08/3/202415:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202415:05GLOBEStructure Therapeutics to Present at Leerink Partners Global..
08/3/202408:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202407:43EDGAR2Form 8-K - Current report
08/3/202407:30GLOBEStructure Therapeutics Reports Fourth Quarter and Full Year..
18/12/202307:28EDGAR2Form 8-K - Current report
18/12/202306:30GLOBEStructure Therapeutics Provides Comprehensive GSBR-1290..
29/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202316:25EDGAR2Form S-1 - General form for registration of securities under..
17/11/202315:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/11/202315:51EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
16/11/202316:13EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
14/11/202315:10GLOBEStructure Therapeutics Reports Third Quarter 2023 Financial..
29/9/202306:50EDGAR2Form 8-K - Current report
29/9/202306:38EDGAR2Form 8-K - Current report
29/9/202306:32GLOBEStructure Therapeutics Announces $300 Million Private..
29/9/202306:30GLOBEStructure Therapeutics Announces Positive Results from Phase..
10/8/202315:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:19EDGAR2Form 8-K - Current report
10/8/202315:05GLOBEStructure Therapeutics Reports Second Quarter 2023 Financial..
04/8/202315:30EDGAR2Form 8-K - Current report
03/8/202316:32GLOBEStructure Therapeutics Appoints Ted W. Love, M.D., to Board..
06/7/202315:05EDGAR2Form 8-K - Current report
07/6/202307:30GLOBEStructure Therapeutics Announces Poster Presentations of its..
31/5/202315:30GLOBEStructure Therapeutics to Present at Jefferies Healthcare..
25/5/202315:30GLOBEStructure Therapeutics Initiates Phase 2a Study of Oral..
18/5/202315:30GLOBEStructure Therapeutics Announces Poster Presentations at the..

Su Consulta Reciente